Cargando…
Correction: Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
Autores principales: | Rana, Tapasi, Chakrabarti, Anwesa, Freeman, Michael, Biswas, Swati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825735/ http://dx.doi.org/10.1371/annotation/95cefb34-2f3d-42a5-b73e-53c531591f0b |
Ejemplares similares
-
Doxorubicin-Mediated Bone Loss in Breast Cancer Bone Metastases Is Driven by an Interplay between Oxidative Stress and Induction of TGFβ
por: Rana, Tapasi, et al.
Publicado: (2013) -
Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone
por: Biswas, Swati, et al.
Publicado: (2011) -
The Role of TGF-β in Bone Metastases
por: Trivedi, Trupti, et al.
Publicado: (2021) -
Role of TGF-β in breast cancer bone metastases
por: Chiechi, Antonella, et al.
Publicado: (2013) -
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
por: Waning, David L., et al.
Publicado: (2015)